These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23118218)

  • 1. Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor.
    Reinart N; Nguyen PH; Boucas J; Rosen N; Kvasnicka HM; Heukamp L; Rudolph C; Ristovska V; Velmans T; Mueller C; Reiners KS; von Strandmann EP; Krause G; Montesinos-Rongen M; Schlegelberger B; Herling M; Hallek M; Fingerle-Rowson G
    Blood; 2013 Jan; 121(5):812-21. PubMed ID: 23118218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of caveolin-1 leads to delayed development of chronic lymphocytic leukemia in Eμ-TCL1 mouse model.
    Shukla A; Cutucache CE; Sutton GL; Pitner MA; Rai K; Rai S; Opavsky R; Swanson PC; Joshi SS
    Exp Hematol; 2016 Jan; 44(1):30-7.e1. PubMed ID: 26435347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD74 is dispensable for development of chronic lymphocytic leukemia in
    Barthel R; Fedorchenko O; Velmans T; Rosen N; Nguyen PH; Reinart N; Florin A; Herling M; Hallek M; Fingerle-Rowson G
    Leuk Lymphoma; 2020 Dec; 61(12):2799-2810. PubMed ID: 32667245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor promotes clearance of pneumococcal colonization.
    Das R; LaRose MI; Hergott CB; Leng L; Bucala R; Weiser JN
    J Immunol; 2014 Jul; 193(2):764-72. PubMed ID: 24928996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage Migration Inhibitory Factor (MIF) Is Essential for Type 2 Effector Cell Immunity to an Intestinal Helminth Parasite.
    Filbey KJ; Varyani F; Harcus Y; Hewitson JP; Smyth DJ; McSorley HJ; Ivens A; Nylén S; Rottenberg M; Löser S; Maizels RM
    Front Immunol; 2019; 10():2375. PubMed ID: 31708913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4 and CD74 together enhance cell survival in response to macrophage migration-inhibitory factor in chronic lymphocytic leukemia.
    Thavayogarajah T; Sinitski D; El Bounkari O; Torres-Garcia L; Lewinsky H; Harjung A; Chen HR; Panse J; Vankann L; Shachar I; Bernhagen J; Koschmieder S
    Exp Hematol; 2022 Nov; 115():30-43. PubMed ID: 36096455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses.
    Balogh KN; Templeton DJ; Cross JV
    PLoS One; 2018; 13(6):e0197702. PubMed ID: 29864117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TBET-expressing Th1 CD4
    Roessner PM; Hanna BS; Öztürk S; Schulz R; Llaó Cid L; Yazdanparast H; Scheffold A; Colomer D; Stilgenbauer S; Lichter P; Seiffert M
    Br J Haematol; 2020 Apr; 189(1):133-145. PubMed ID: 31724172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia.
    Hanna BS; Öztürk S; Seiffert M
    Mol Immunol; 2019 Jun; 110():77-87. PubMed ID: 29173971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape.
    Patrussi L; Capitani N; Ulivieri C; Manganaro N; Granai M; Cattaneo F; Kabanova A; Mundo L; Gobessi S; Frezzato F; Visentin A; Finetti F; Pelicci PG; D'Elios MM; Trentin L; Semenzato G; Leoncini L; Efremov DG; Baldari CT
    Haematologica; 2019 Oct; 104(10):2040-2052. PubMed ID: 30819907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the splenic microenvironment in chronic lymphocytic leukemia development in Eµ-TCL1 transgenic mice.
    Collard JP; McKenna MK; Noothi SK; Alhakeem SS; Rivas JR; Rangnekar VM; Muthusamy N; Bondada S
    Leuk Lymphoma; 2022 Aug; 63(8):1810-1822. PubMed ID: 35258388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Macrophage and Dendritic Cell Response in
    Sánchez-Zamora YI; Juarez-Avelar I; Vazquez-Mendoza A; Hiriart M; Rodriguez-Sosa M
    J Diabetes Res; 2016; 2016():7053963. PubMed ID: 27699180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for macrophage migration inhibitory factor in protective immunity against Aspergillus fumigatus.
    Stojanovic I; Mirkov I; Kataranovski M; Glamoclija J; Stosic-Grujicic S
    Immunobiology; 2011 Sep; 216(9):1018-27. PubMed ID: 21489649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor is essential for eosinophil recruitment in allergen-induced skin inflammation.
    Yoshihisa Y; Makino T; Matsunaga K; Honda A; Norisugi O; Abe R; Shimizu H; Shimizu T
    J Invest Dermatol; 2011 Apr; 131(4):925-31. PubMed ID: 21191413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling.
    Greene JT; Mani R; Ramaswamy R; Frissora F; Yano M; Zapolnik K; Harrington B; Wasmuth R; Tran M; Mo X; McKenna M; Rangnekar VM; Byrd JC; Bondada S; Muthusamy N
    Blood Adv; 2019 Apr; 3(8):1255-1266. PubMed ID: 30987970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanism.
    Grioni M; Brevi A; Cattaneo E; Rovida A; Bordini J; Bertilaccio MTS; Ponzoni M; Casorati G; Dellabona P; Ghia P; Bellone M; Calcinotto A
    Blood Adv; 2021 Jul; 5(14):2817-2828. PubMed ID: 34269799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migration inhibitory factor (MIF) released by macrophages upon recognition of immune complexes is critical to inflammation in Arthus reaction.
    Paiva CN; Arras RH; Magalhães ES; Alves LS; Lessa LP; Silva MH; Ejzemberg R; Canetti C; Bozza MT
    J Leukoc Biol; 2009 May; 85(5):855-61. PubMed ID: 19188484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression.
    Dong S; Harrington BK; Hu EY; Greene JT; Lehman AM; Tran M; Wasmuth RL; Long M; Muthusamy N; Brown JR; Johnson AJ; Byrd JC
    J Clin Invest; 2019 Jan; 129(1):122-136. PubMed ID: 30457982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of macrophage migration inhibitory factor in corneal neovascularization.
    Usui T; Yamagami S; Kishimoto S; Seiich Y; Nakayama T; Amano S
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3545-50. PubMed ID: 17652722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages.
    Prieto-Lafuente L; Gregory WF; Allen JE; Maizels RM
    J Leukoc Biol; 2009 May; 85(5):844-54. PubMed ID: 19179453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.